Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities
Net income	$ 14,038	$ 15,263
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	17,365	7,732
Amortization of deferred loan fees and line of credit fees	296	357
Amortization of label design fees	668	251
Litigation proceeds	0	(4,750)
Stock-based compensation expense	1,943	601
Provision for doubtful accounts	45	87
Impairment of inventory	0	3,302
Net unrealized gain on interest rate swap agreements	(8,582)	(8,212)
(Benefit) provision for deferred income tax	888	0
Loss (gain) on disposition of assets	508	(999)
Deferred gain on sale leaseback	(1,000)	(1,000)
Deferred rent	285	376
Change in operating assets and liabilities (net of effect of business combinations):
Accounts receivable	(21,261)	(1,001)
Related party receivables	0	(2,038)
Other receivables	376	(2,338)
Litigation receivable	0	4,750
Inventories	4,244	(8,964)
Prepaid expenses and other current assets	(2,232)	(5,829)
Other assets	(6,215)	1,688
Accounts payable	(8,106)	616
Accrued liabilities and other payables	2,836	16,073
Related party liabilities	0	3,698
Net cash (used in) provided by operating activities	(3,903)	19,661
Cash flows from investing activities
Proceeds from disposition of assets	105	1,064
Purchases of property, plant, and equipment	(15,723)	(30,688)
Label design expenditures	(225)	(375)
Proceeds on related party notes receivable	0	756
Acquisition of businesses	(74,268)	0
Net cash used in investing activities	(90,111)	(29,243)
Cash flows from financing activities
Repurchase of common stock	(2,833)	0
Principal payments on line of credit	(67,210)	(25,195)
Proceeds from line of credit	126,591	32,281
Outstanding checks in excess of cash	2,900	9,277
Principal payments on long-term debt	(13,178)	(15,234)
Proceeds from long-term debt	0	8,902
Principal payments on related party note	0	(489)
Deferred offering costs	0	(768)
Payments on acquisition payable	(226)	(486)
Net cash provided by financing activities	46,044	8,287
Net change in cash and restricted cash	(47,970)	(1,295)
Cash and restricted cash, beginning of period	123,679	1,751
Cash and restricted cash, end of period	75,709	456
Cash paid during the period for:
Interest	9,508	9,230
Income taxes	22	25
Noncash investing and financing activities:
Contingent consideration in a business combination	8,460	0
Issuance of common stock in business combination	10,521
Accretion of redemption value of Series B redeemable cumulative stock	0	4,760
Accretion of redemption value of Series A redeemable stock	0	16,466
Offering costs	$ 0	$ 535